01/07/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

01/07/2024

Jul 1, 2024, 23:51 | Insight
Piotr Wysocki: Neoadjuvant therapy for renal-cell cancer patients is still in its infancy, unlike in melanoma
Piotr Wysocki recently posted on LinkedIn: "The PROSPER ECOG-ACRIN EA8143 study (published online in Lancet…
Jul 1, 2024, 19:36 | Blog
Monica Bertagnolli: Molecular Portrait of Key Driver of pancreatic cancer
Monica Bertagnolli shared on LinkedIn: “A pancreatic cancer diagnosis is frightening. NIH-funded research may offer…
Jul 1, 2024, 19:24 | Insight
Léa Ikhlef: The use of extracellular vesicles as a communication tool by TAMS in CLL
Léa Ikhlef, Postdoctoral researcher at Léon Bérard Center, shared on LinkedIn: “I'm glad to share…
Jul 1, 2024, 19:16 | Insight
Susanna Greer: This researcher is making tools to improve quality of life
Susanna Greer, Chief Scientific Officer at The V Foundation for Cancer Research, shared on LinkedIn:…
Jul 1, 2024, 19:04 | Blog
Julie S. Torode: Ethiopia‘s first ever breast cancer guideline
Julie S. Torode, Board Member and Director of Strategic Partnerships of Institute of Cancer Policy,…
Jul 1, 2024, 18:48 | Blog
Yüksel Ürün: Empowering Cancer Survivors with Employment Support!
Yüksel Ürün shared a post on X: “Empowering Cancer Survivors with Employment Support! Many cancer…
Jul 1, 2024, 18:24 | Insight
Paolo Tarantino: How long should adjuvant T-DM1 be given for stage I HER2+ eBC?
Paolo Tarantino shared on X: "For how long should adjuvant T-DM1 be given for stage…
Jul 1, 2024, 18:12 | Blog
Two great minds teaming up to fight cancer - Saint John’s Cancer Institute
Saint John’s Cancer Institute posted on LinkedIn: “A Shared Vision: Two great minds, two great…
Jul 1, 2024, 18:02 | Blog
Kai-Cheng Hsu: 25 Years of Innovation and Excellence in Biomedical Technology!
Kai-Cheng Hsu shared a post on LinkedIn: “Celebrating 25 Years of Innovation and Excellence in…
Jul 1, 2024, 17:38 | Blog
Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients
Sara Elena Rebuzzi, Medical Oncologis at The Hospital of San Paolo, made the following post…
All: 99 Posts: 1 - 10
Special Coverage